Blend Uniformity
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
Testing performed on a powder or granule blend, before compression or encapsulation, that confirms the active pharmaceutical ingredient is homogeneously distributed throughout the blend at the target concentration, mitigating the risk that individual finished dosage units will fail content uniformity due to segregation, poor mixing, or an inadequate blending process.
Blend uniformity is an in-process control performed at defined blender locations and time points; a failing or borderline result at this stage predicts — and can allow correction of — a downstream content uniformity failure before an entire batch of finished dosage units is manufactured.
Sampling technique is a known source of false blend non-uniformity results, since a thief probe can itself disturb the blend or preferentially sample certain particle sizes, which is why sampling location and method are validated alongside the analytical test.
For low-dose, poorly flowing, or segregation-prone formulations, blend uniformity is a particularly high-risk control point and is frequently supplemented by process analytical technology such as near-infrared spectroscopy for continuous, non-destructive monitoring.
- —An in-process control predicting downstream content uniformity performance.
- —Sampled at defined blender positions and time points, not just at blend completion.
- —Thief-probe sampling technique itself can introduce a false non-uniformity result.
- —Often supported by process analytical technology (e.g., near-infrared spectroscopy) for continuous monitoring.
FDA Guidance for Industry: Powder Blends and Finished Dosage Units — Stratified In-Process Dosage Unit Sampling and Assessment (2003); USP <905>
Frequently asked questions
What is Blend Uniformity?
Testing performed on a powder or granule blend, before compression or encapsulation, that confirms the active pharmaceutical ingredient is homogeneously distributed throughout the blend at the target concentration, mitigating the risk that individual finished dosage units will fail content uniformity due to segregation, poor mixing, or an inadequate blending process.
Which regulations cover Blend Uniformity?
FDA Guidance for Industry: Powder Blends and Finished Dosage Units — Stratified In-Process Dosage Unit Sampling and Assessment (2003); USP <905>